Ibex Medical Analytics vs Mindpeak (2026)
Two computational pathology companies doing different work on the same slide. Ibex detects cancer, with prostate, breast and gastric solutions in routine clinical use, United States clearance as an in vitro diagnostic for the prostate product, peer reviewed publication behind it and the most complete published certification set of any vendor in this index. Mindpeak quantifies biomarkers rather than finding tumours, with eleven European marked algorithms covering breast markers and lung immunotherapy scoring, distributed both directly and embedded inside a partner platform. A laboratory looking to catch what a pathologist might miss on a prostate biopsy is buying Ibex. One trying to make its immunohistochemistry scoring reproducible across pathologists is buying Mindpeak. The regimes differ too, so check that the product you want is usable for diagnosis in your market, not just available in it.
- The certification set is the most complete of any vendor in this index, and the deployment evidence is verifiable through third parties rather than resting on vendor claims.
- The cleared indication is one of the most conservative and best constructed here, which is the right posture for software that flags cancer on a slide a pathologist will sign.
- Three cancer types are in routine clinical use worldwide, covering prostate, breast and gastric, with peer reviewed publication behind the deployment scale.
- Eleven marked algorithms across the highest volume biomarker workload in European pathology, covering breast markers and lung immunotherapy scoring rather than cancer detection alone.
- Genuinely independent published evidence exists, which is rarer in this lane than it should be, and the technical claim about its breast immunohistochemistry model is specific and checkable.
- Reach comes through platform distribution as well as direct sale, so a laboratory already running a partner platform can adopt the algorithms without a separate integration project.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Ibex Medical Analytics and Mindpeak are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Ibex Medical Analytics | Mindpeak |
|---|---|---|
| Primary category | Digital Pathology AI | Digital Pathology AI |
| Founded | 2016 | 2018 |
| Headquarters | Tel Aviv, Israel | Hamburg, Germany |
| Website | ibex-ai.com | mindpeak.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Ibex Medical Analytics its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Security Certifications and Trust Center. Set against Mindpeak, Ibex Medical Analytics grades higher on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Mindpeak its top capability grade on AI Centrality. Set against Ibex Medical Analytics, Mindpeak grades higher on EHR and Interoperability Depth. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Ibex Medical Analytics or Mindpeak?
On the axes where the AI Health Index separates them, Ibex Medical Analytics grades higher on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and AI Safety and PHI Stewardship, and Mindpeak grades higher on EHR and Interoperability Depth. Ibex Medical Analytics leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Ibex Medical Analytics and Mindpeak differ most?
The widest separation the AI Health Index records between Ibex Medical Analytics and Mindpeak is on Security Certifications and Trust Center, where Ibex Medical Analytics grades A and Mindpeak grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Ibex Medical Analytics and Mindpeak grade the same?
The AI Health Index grades Ibex Medical Analytics and Mindpeak the same on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Ibex Medical Analytics and Mindpeak not disclosed?
At the last review, at least one of Ibex Medical Analytics and Mindpeak published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Digital Pathology AI page.
The regulatory regimes differ and are not interchangeable: one holds United States clearance as an in vitro diagnostic, the other holds a European marked portfolio, and a product available for clinical use in one market may not be usable for diagnosis in the other.
Mindpeak publishes no information security management certification and no health privacy position; Ibex publishes no explicit business associate commitment though its certification set is closely aligned with the privacy requirements. Neither publishes pricing. Neither publishes a bias evaluation, and staining and scanner variation between laboratories remains the largest uncontrolled variable in both products.